arrow
C

Catherine P. Benziger

Harvard University
H指数:21
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating fitness-for-use of electronic health records in ascertaining baseline characteristics and clinical outcomes in clinical trials: insights from the VESALIUS EHR demonstration project

评估电子健康记录在确定临床试验基线特征和临床结局的适用性:VESALIUS EHR演示项目的启示

2026-04-250
OA
Dual versus monotherapy with SGLT2 inhibitor and GLP-1 receptor agonist: PRECIDENTD pragmatic randomized trial

SGLT2抑制剂和GLP-1受体激动剂的双药治疗与单药治疗比较:PRECIDENTD务实性随机试验

2026-04-010
PRE
Impacts of the COVID-19 era Practice of Preventing Bypass of the Emergency Department for ST-Segment Elevation Myocardial Infarction Patients Identified in the Field by Emergency Medical Services on In-Hospital Mortality and Other Performance Metrics

COVID-19时期预防急诊科绕行实践对院前由急救医疗服务识别的ST段抬高型心肌梗死患者院内死亡率及其他绩效指标的影响

2024-11-120
PRE
Prevalence of Cardiovascular Risk Factors in Pediatric Patients in a Large Rural Health System

大型农村医疗体系中儿科患者心血管风险因素的患病率

2024-11-120
PRE
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients

阿司匹林用于男性和女性患者动脉粥样硬化性心血管疾病二级预防的剂量

2024-09-011
PRE
Contribution of Clinical Trial Event Data by Data Source A Prespecified Analysis of the ADAPTABLE Randomized Clinical Trial
2024-09-010
PRE
Angiographic characteristics of patients with STEMI and COVID-19: Insights from NACMI registry
2024-05-010
PRE
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease

年龄和阿司匹林剂量在动脉粥样硬化性心血管疾病二级预防中的作用

2024-02-201
OAAI
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
2023-11-014
OAAI